These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2949492

  • 1. Relationships between chemical structures and antimitotic activities of a group of colchicine alkaloids.
    Dvorácková S, Guénard D, Picot F, Simánek V, Waisser K.
    Acta Univ Palacki Olomuc Fac Med; 1985; 111():13-22. PubMed ID: 2949492
    [No Abstract] [Full Text] [Related]

  • 2. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B, Panda D, Gupta S, Banerjee M.
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [Abstract] [Full Text] [Related]

  • 3. Colchicine prodrugs and codrugs: Chemistry and bioactivities.
    Ghawanmeh AA, Chong KF, Sarkar SM, Bakar MA, Othaman R, Khalid RM.
    Eur J Med Chem; 2018 Jan 20; 144():229-242. PubMed ID: 29274490
    [Abstract] [Full Text] [Related]

  • 4. Molecular features of colchicine associated with antimitotic activity and inhibition of tubulin polymerization.
    Fitzgerald TJ.
    Biochem Pharmacol; 1976 Jun 15; 25(12):1383-7. PubMed ID: 938560
    [No Abstract] [Full Text] [Related]

  • 5. Cornigerine, a potent antimitotic Colchicum alkaloid of unusual structure. Interactions with tubulin.
    Hamel E, Ho HH, Kang GJ, Lin CM.
    Biochem Pharmacol; 1988 Jun 15; 37(12):2445-9. PubMed ID: 3390207
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of colchicine and its B-ring modified analog MTPT on the assembly-independent GTPase activity of purified beta-tubulin isoforms from bovine brain.
    Banerjee A.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):698-700. PubMed ID: 9070875
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
    Bowdon BJ, Waud WR, Wheeler GP, Hain R, Dansby L, Temple C.
    Cancer Res; 1987 Mar 15; 47(6):1621-6. PubMed ID: 3815360
    [Abstract] [Full Text] [Related]

  • 8. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
    Batra JK, Jurd L, Hamel E.
    Mol Pharmacol; 1985 Jan 15; 27(1):94-102. PubMed ID: 3965931
    [Abstract] [Full Text] [Related]

  • 9. Recent progress in structure-activity relationship studies on the anticancer drug colchicine and its analogues.
    Pan XD, Fang WS.
    Yao Xue Xue Bao; 2002 Oct 15; 37(10):821-7. PubMed ID: 12567870
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of mitosis by glycopeptide dendrimer conjugates of colchicine.
    Lagnoux D, Darbre T, Schmitz ML, Reymond JL.
    Chemistry; 2005 Jun 20; 11(13):3941-50. PubMed ID: 15861378
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
    Lai MJ, Kuo CC, Yeh TK, Hsieh HP, Chen LT, Pan WY, Hsu KY, Chang JY, Liou JP.
    ChemMedChem; 2009 Apr 20; 4(4):588-93. PubMed ID: 19266513
    [Abstract] [Full Text] [Related]

  • 12. [Protein synthesis during the period of mitotic recovery following exposure to colchicine and colcemide].
    Kazan'ev EV, Zapara OM.
    Biull Eksp Biol Med; 1977 May 20; 83(5):588-9. PubMed ID: 884267
    [Abstract] [Full Text] [Related]

  • 13. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
    Fortin S, Labrie P, Moreau E, Wei L, Kotra LP, C-Gaudreault R.
    Bioorg Med Chem; 2008 Feb 15; 16(4):1914-26. PubMed ID: 18023585
    [Abstract] [Full Text] [Related]

  • 14. Interaction of novel thiocolchicine analogs with the tubulin isoforms from bovine brain.
    Banerjee A, Kasmala LT, Hamel E, Sun L, Lee KH.
    Biochem Biophys Res Commun; 1999 Jan 19; 254(2):334-7. PubMed ID: 9918839
    [Abstract] [Full Text] [Related]

  • 15. [Chemistry and mode of action of colchicine and its derivatives].
    Werner D, Dönges KH.
    Planta Med; 1972 Nov 19; 22(3):306-15. PubMed ID: 4675286
    [No Abstract] [Full Text] [Related]

  • 16. [Individual sensitivity of epidermal tumors treated in vitro with an antimitotic agent: colchicine].
    Bouchard J.
    Bull Cancer; 1971 Nov 19; 58(4):495-510. PubMed ID: 5153615
    [No Abstract] [Full Text] [Related]

  • 17. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP.
    J Med Chem; 2006 Oct 19; 49(21):6412-5. PubMed ID: 17034147
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of tubulin polymerization: synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III.
    Passarella D, Giardini A, Peretto B, Fontana G, Sacchetti A, Silvani A, Ronchi C, Cappelletti G, Cartelli D, Borlak J, Danieli B.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6269-85. PubMed ID: 18468444
    [Abstract] [Full Text] [Related]

  • 19. [Colchicine method of determining duration of mitosis in bodily tissues].
    Dobrokhotov VN, Valvas VS, Vasil'eva VI, Ivanova LN, Kudriavtseva AS.
    Biull Eksp Biol Med; 1980 Apr 01; 89(4):483-5. PubMed ID: 7388167
    [Abstract] [Full Text] [Related]

  • 20. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
    Nguyen TL, McGrath C, Hermone AR, Burnett JC, Zaharevitz DW, Day BW, Wipf P, Hamel E, Gussio R.
    J Med Chem; 2005 Sep 22; 48(19):6107-16. PubMed ID: 16162011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.